CENVERT Betahistine 16mg Tablet 1's
CENVERT-A3Z295
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indication
For the treatment of vertigo, tinnitus, hearing loss, and nausea.
Dosage
Initially, 8-16 mg tid. Maintenance: 24-48 mg daily in divided doses.
Administration
May be taken with or without food.
Contraindications
Phaeochromocytoma, active or history of peptic ulcer.
Special Precautions
Patient with bronchial asthma, CV disease, urticaria, rashes, allergic rhinitis. Patient taking antihistamines. Hepatic impairment. Pregnancy and lactation.
Storage
Store between 15-30°C. Protect from moisture and light.
MedsGo Class
Antivertigo Drugs
Features
Brand
CENVERT
Full Details
Dosage Strength
16mg
Drug Ingredients
- Betahistine
Drug Packaging
Tablet 1's
Generic Name
Betahistine
Dosage Form
Tablet
Registration Number
DRP-6676
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply